O'Donnell PH, Arkenau HT, Sridhar SS, Ong M, et al. Patient-reported outcomes and inflammatory biomarkers in patients with locally
advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2
dose-escalation study 1108. Cancer 2020;126:432-443.
PMID: 31581306